Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

0.5700 -0.0430 (-7.01%)
Streaming Delayed Price Updated: 12:19 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 237,823
Open 0.6193
Bid (Size) 0.5720 (3)
Ask (Size) 0.5737 (7)
Prev. Close 0.6130
Today's Range 0.5606 - 0.6230
52wk Range 0.5908 - 2.530
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023
BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga

Performance

YTD
-62.75%
-62.75%
1 Month
-56.15%
-56.15%
3 Month
-52.50%
-52.50%
6 Month
-56.82%
-56.82%
1 Year
-49.11%
-49.11%

More News

Read More
Earnings Scheduled For March 26, 2024
Via Benzinga
Earnings Preview For BioLine Rx
Via Benzinga
BioLine Rx Earnings Preview
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
Via Benzinga
BioLineRx Ltd. (NASDAQ: BLRX) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
Via FinancialNewsMedia
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
Via InvestorPlace
Earnings Scheduled For November 20, 2023
Via Benzinga
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
Via Talk Markets
A Preview Of BioLine Rx's Earnings
Via Benzinga
A Preview Of BioLine Rx's Earnings
Via Benzinga
3 Tech Stocks That Wall Street Loves More Than Nvidia
Via InvestorPlace
3 Top Penny Stocks to Make You a Millionaire in 5 Years
Via InvestorPlace
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
Via Benzinga
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Earnings Scheduled For August 30, 2023
Via Benzinga
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
Via InvestorPlace
3 Smart Penny Stocks with Huge Potential
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
Via InvestorPlace
7 High-Potential Penny Stocks in the Biotech Sector
Via InvestorPlace
NASDAQ:BLRX Long Term Shareholder Alert: Investigation of Potential Wrongdoing at BioLineRx Ltd.
Via SBWire
The 3 Best Biotech Stocks Under $1 to Buy for April
Via InvestorPlace
Earnings Scheduled For May 24, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.